Treatment of Children with All Stages of Hepatoblastoma.
Clinical Trial Information
Trial Contact: Boettger, Sadie; El-Shami, Jessica; Francois, Laetitia Claire; Spinelli, Jennifer
IRB No: AHEP0731
Protocol Abbrev: AHEP0731
Principal Investigator: Vincent F. Giusti, MD
Sub Investigators: AguilarBonilla, Ana MD; Eslin, Don MD; Martin, Rebecca, ARNP; Pope, Michele ARNP; Smith, Amy MD; Story, Allison ARNP; Sullivan Darden, Kelly ARNP; Sutphin, Robert MD; Wieber, Laura ARNP; Levy, Alejandro MD
Phase: Drug: Phase III
Age Group: Pediatric
Secondary Protocol No: AHEP0731
Treatment: Procedure: Surgery Drug: Chemotherapy (multiple) Procedure: Liver Transplantation Other: Laboratory Biomarker Analysis
Applicable Disease Sites: Liver
Therapies Involved: Surgery; Radiation
ClinicalTrials.gov ID: NCT00980460
This trial studies the side effects and how well risk-based therapy works in treating younger patients with newly diagnosed liver cancer.
Ages Eligible for Study: up to 21 Years; Genders Eligible for Study: Both; Accepts Healthy Volunteers: No